To evaluate metabolic and genetic abnormalities in children with nephrolithiasis attending a referral center in North India.
The patients aged 1–18 y old with nephrolithiasis underwent biochemical evaluation and whole-exome sequencing. The authors evaluated for monogenic variants in 56 genes and compared allele frequency of 39 reported polymorphisms between patients and 1739 controls from the GenomeAsia 100 K database.
Fifty-four patients, aged 9.1 ± 3.7 y were included. Stones were bilateral in 42.6%, familial in 33.3%, and recurrent in 25.9%. The most common metabolic abnormalities were hypercalciuria (35.2%), hyperoxaluria (24.1%), or both (11.1%), while xanthinuria (n = 3), cystinuria (n = 1), and hyperuricosuria (n = 1) were rare. Exome sequencing identified an etiology in 6 (11.1%) patients with pathogenic/likely pathogenic causative variants. Three variants in MOCOS and one in ATP7B were pathogenic; likely pathogenic variants included MOCOS (n = 2), AGXT, and SLC7A9 (n = 1, each). Causality was not attributed to two SLC34A1 likely pathogenic variants, due to lack of matching phenotype and dominant family history. Compared to controls, allele frequency of the polymorphism TRPV5 rs4252402 was significantly higher in familial stone disease (allele frequency 0.47 versus 0.53; OR 3.2, p = 0.0001).
The chief metabolic abnormalities were hypercalciuria and hyperoxaluria. A monogenic etiology was identified in 11% with pathogenic or likely pathogenic variants using a gene panel for nephrolithiasis. Heterozygous missense variants in the sodium-phosphate cotransporter SLC34A1 were common and required evaluation for attributing pathogenicity. Rare polymorphisms in TRPV5 might increase the risk of familial stones. These findings suggest that a combination of metabolic and genetic evaluation is useful for determining the etiology of nephrolithiasis.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Sas DJ. An update on the changing epidemiology and metabolic risk factors in pediatric kidney stone disease. Clin J Am Soc Nephrol. 2011;6:2062–8.
Spivacow FR, Del Valle EE, Boailchuk JA, Sandoval Diaz G, Rodriguez Ugarte V, Arreaga AZ. Metabolic risk factors in children with kidney stone disease: an update. Pediatr Nephrol. 2020;35:2107–12.
Penido MG, Srivastava T, Alon US. Pediatric primary urolithiasis: 12-year experience at a Midwestern children’s hospital. J Urol. 2013;189:1493–7.
Hari P, Bagga A, Vasudev V, Singh M, Srivastava RN. Aetiology of nephrolithiasis in north Indian children. Pediatr Nephrol. 1995;9:474–5.
Ramya K, Krishnamurthy S, Manikandan R, Sivamurukan P, Naredi BK, Karunakar P. Metabolic and clinical characteristics of children with urolithiasis from southern India. Indian J Pediatr. 2021;88:345–50.
Halbritter J, Baum M, Hynes AM, et al. Fourteen monogenic genes account for 15% of nephrolithiasis/nephrocalcinosis. J Am Soc Nephrol. 2015;26:543–51.
Daga A, Majmundar AJ, Braun DA, et al. Whole exome sequencing frequently detects a monogenic cause in early onset nephrolithiasis and nephrocalcinosis. Kidney Int. 2018;93:204–13.
Braun DA, Lawson JA, Gee HY, et al. Prevalence of monogenic causes in pediatric patients with nephrolithiasis or nephrocalcinosis. Clin J Am Soc Nephrol. 2016;11:664–72.
Taguchi K, Yasui T, Milliner DS, Hoppe B, Chi T. Genetic risk factors for idiopathic urolithiasis: a systematic review of the literature and causal network analysis. Eur Urol Focus. 2017;3:72–81.
Amar A, Majmundar AJ, Ullah I, et al. Gene panel sequencing identifies a likely monogenic cause in 7% of 235 Pakistani families with nephrolithiasis. Hum Genet. 2019;138:211–9.
de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J. Development of a WHO growth reference for school–aged children and adolescents. Bull World Health Organ. 2007;85:660–7.
Elkoushy MA, Andonian S. Characterization of patients with heterozygous cystinuria. Urology. 2012;80:795–9.
Matos V, van Melle G, Boulat O, Markert M, Bachmann C, Guignard JP. Urinary phosphate/creatinine, calcium/creatinine, and magnesium/creatinine ratios in a healthy pediatric population. J Pediatr. 1997;131:252–7.
Bagga A, Sinha A. Renal tubular acidosis. Indian J Pediatr. 2020;87:733–44.
Elisaf M, Panteli K, Theodorou J, Siamopoulos KC. Fractional excretion of magnesium in normal subjects and in patients with hypomagnesemia. Magnes Res. 1997;10:315–20.
Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med. 2015;17:405–24.
Naseri M, Varasteh AR, Alamdaran SA. Metabolic factors associated with urinary calculi in children. Iran J Kidney Dis. 2010;4:32–8.
VanDervoort K, Wiesen J, Frank R, et al. Urolithiasis in pediatric patients: a single center study of incidence, clinical presentation and outcome. J Urol. 2007;177:2300–5.
Lieberman E. Importance of metabolic contributions to urolithiasis in pediatric patients. Mayo Clin Proc. 1993;68:313–5.
Rizvi SA, Sultan S, Zafar MN, et al. Evaluation of children with urolithiasis. Indian J Urol. 2007;23:420–7.
Neuhaus TJ, Belzer T, Blau N, Hoppe B, Sidhu H, Leumann E. Urinary oxalate excretion in urolithiasis and nephrocalcinosis. Arch Dis Child. 2000;82:322–6.
Glew RH, Sun Y, Horowitz BL, et al. Nephropathy in dietary hyperoxaluria: a potentially preventable acute or chronic kidney disease. World J Nephrol. 2014;3:122–42.
Schlingmann KP, Ruminska J, Kaufmann M, et al. Autosomal-recessive mutations in SLC34A1 encoding sodium-phosphate cotransporter 2a cause idiopathic infantile hypercalcemia. J Am Soc Nephrol. 2016;27:604–14.
Mitra P, Pal DK, Das M. Association of TRPV5 gene polymorphism with calcium urolithiasis: a case-control study from West Bengal. India World J Urol. 2020;38:1311–22.
Makras P, Yavropoulou MP, Kassi E, Anastasilakis AD, Vryonidou A, Tournis S. Management of parathyroid disorders: recommendations of the working group of the bone section of the hellenic endocrine society. Hormones (Athens). 2020;19:581–91.
Kirejczyk JK, Porowski T, Konstantynowicz J, et al. Urinary citrate excretion in healthy children depends on age and gender. Pediatr Nephrol. 2014;29:1575–82.
Nevo A, Shahait M, Shah A, Jackman S, Averch T. Defining a clinically significant struvite stone: a non–randomized retrospective study. Int Urol Nephrol. 2019;51:585–91.
Ichida K, Matsumura T, Sakuma R, Hosoya T, Nishino T. Mutation of human molybdenum cofactor sulfurase gene is responsible for classical xanthinuria type II. Biochem Biophys Res Commun. 2001;282:1194–200.
M’Dimegh S, Omezzine A, M’Barek I, et al. Mutational analysis of Agxt in Tunisian population with primary hyperoxaluria type 1. Ann Hum Genet. 2017;81:1–10.
Aggarwal A, Chandhok G, Todorov T, et al. Wilson disease mutation pattern with genotype-phenotype correlations from Western India: confirmation of p.C271* as a common Indian mutation and identification of 14 novel mutations. Ann Hum Genet. 2013;77:299–307.
Conflict of Interest
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Below is the link to the electronic supplementary material.
About this article
Cite this article
Mandal, A., Khandelwal, P., Geetha, T.S. et al. Metabolic and Genetic Evaluation in Children with Nephrolithiasis. Indian J Pediatr 89, 1243–1250 (2022). https://doi.org/10.1007/s12098-022-04234-9